Phase II Trial of Carboplatin and Bevacizumab for Progressive Breast Cancer Brain Metastases.
Phase of Trial: Phase II
Latest Information Update: 25 May 2017
At a glance
- Drugs Bevacizumab (Primary) ; Carboplatin; Trastuzumab
- Indications Breast cancer; Cancer metastases
- Focus Therapeutic Use
- 10 Apr 2017 Status changed from active, no longer recruiting to completed.
- 21 Jan 2014 Planned End Date changed from 1 Oct 2013 to 1 Feb 2016 as per ClinicalTrials.gov record.
- 11 Sep 2012 Planned End Date changed from 1 Oct 2011 to 1 Oct 2013 as reported by ClinicalTrials.gov.